Cipla shares rally on anti-asthma inhaler launch in Germany

Posted By:
Subscribe to GoodReturns

Shares in Cipla jumped sharply by 7 per cent after the pharma major launched an anti-asthma inhaler in Germany and Sweden. the stock was last trading at Rs 564 on the Bombay Stock Exchange.

The inhaler is a generic version of GlaxoSmithKline Plc's Advair.

Noted broking firm, Emkay Global upgraded the stock to "buy" from "accumulate" with a target of 671 rupees.

Overall addressable opportunity of generic Advair is $800 million in Europe, Emkay said.

Cipla shares were trading up 7.1 percent to 566.75 rupees as of 10:02 a.m.

Read more about: cipla
Story first published: Tuesday, September 2, 2014, 11:05 [IST]
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


Get Latest News alerts from Goodreturns